Details of the Target
General Information of Target
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
YN-1 Probe Info |
![]() |
N.A. | LDD0447 | [1] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
STS-1 Probe Info |
![]() |
N.A. | LDD0137 | [2] |
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Lampalizumab | Antibody | DM7Z6Y |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Anti-factor D | Antibody | D08ZDI | |||
Ach-4471 | . | D0C9MA |
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
34-dichloroisocoumarin | Small molecular drug | DB04459 | |||
Example 373 [Wo2012093101] | Small molecular drug | D04MIN | |||
2-aminobenzyl Alcohol | . | DB03058 | |||
Hc3-1496 | . | D0P8LR |
References